News

Antares Pharma announced that the FDA has approved Otrexup injection, the first SC methotrexate for once-weekly self-administration with an easy-to-use, single-dose, disposable auto-injector.
This formulation incorporates the previously MHLW-approved Metoject Subcutaneous Injection pre-filled syringe formulation in a pen-type autoinjector and was developed to reduce the burden on ...
A new self-administered methotrexate autoinjector had 90.5% subject usability, according to recently published data. Christophe Hudry, MD, of the rheumatology department at Cochin Hospital in ...
Rasuvo, delivered in an auto-injector, is approved for rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis and psoriasis and will be available in 10 dosage strengths.
Antares Pharma announced the availability of Otrexup (methotrexate for subcutaneous injection) for once-weekly self-administration with a single-dose disposable auto-injector.
Antares plans to initiate a development program utilizing a proprietary auto injector device with doses of methotrexate not commercially approved or available in an auto injector in order to ...
TORONTO--(BUSINESS WIRE)--NORDIC PHARMA, a SEVER Life Sciences company, announced today the submission of a New Drug Submission to Health Canada for its methotrexate auto-injector, Nordimet ® for ...
The abstract, entitled "Drug exposure limitations of oral methotrexate (MTX) at doses ≥15mg may be overcome by using a subcutaneous MTX auto-injector in patients with rheumatoid arthritis (RA ...
TORONTO — NORDIC PHARMA, a SEVER Life Sciences company, announced today the submission of a New Drug Submission to Health Canada for its methotrexate auto-injector, Nordimet ® for the treatment of ...
Pegloticase (Krystexxa) injection coadministered with methotrexate received FDA approval for the treatment of gout.
As part of the Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving KRYSTEXXA trial [MIRROR randomized controlled trial (RCT)], baseline estimated glomerular ...